Chenodeoxycholic acid API Manufacturers

Looking for Chenodeoxycholic acid API 474-25-9?

Description:

Here you will find a list of producers, manufacturers and distributors of Chenodeoxycholic acid. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

Chenodeoxycholic acid 

Synonyms:

Anthropodeoxycholic acid , Anthropodesoxycholic acid , CDCA , Chenic acid , Chenix , Chenocholic acid , Chenodeoxycholic acid , Chenodesoxycholic acid , Chenodiol , Gallodesoxycholic acid , Chenodeoxycholzuur  

Cas Number:

474-25-9 

DrugBank number:

DB06777 

Unique Ingredient Identifier:

0GEI24LG0J

Chenodeoxycholic acid is a type of Bile acid preparations

Bile acid preparations are a subcategory of pharmaceutical active pharmaceutical ingredients (APIs) that are derived from natural bile acids. Bile acids are synthesized in the liver and play a crucial role in the digestion and absorption of dietary fats. These preparations are commonly used in the pharmaceutical industry for various therapeutic purposes.

Bile acid preparations are known for their ability to facilitate the solubilization and absorption of poorly soluble drugs, thereby enhancing their bioavailability. They can be used in the formulation of oral solid dosage forms, such as tablets and capsules, to improve drug dissolution and systemic absorption.

Moreover, bile acid preparations also exhibit therapeutic properties on their own. They are used in the treatment of certain liver disorders, such as cholestasis, where the flow of bile from the liver is impaired. These preparations help restore bile flow and promote the excretion of bile acids, aiding in the management of liver conditions.

In addition, bile acid preparations have shown potential in the treatment of metabolic disorders, including dyslipidemia and obesity. By modulating lipid metabolism, they can help reduce cholesterol levels and promote weight loss.

Overall, bile acid preparations are versatile pharmaceutical APIs that offer multiple benefits, including enhanced drug solubility, improved bioavailability, and therapeutic effects on liver and metabolic disorders. Their use in the pharmaceutical industry continues to expand, offering new opportunities for drug development and patient care.

Chenodeoxycholic acid (Bile acid preparations), classified under Gastrointestinal Agents

Gastrointestinal Agents belong to the pharmaceutical API category that focuses on treating disorders and ailments related to the digestive system. These agents play a crucial role in addressing various gastrointestinal conditions, such as acid reflux, ulcers, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD).

One of the key types of gastrointestinal agents is proton pump inhibitors (PPIs), which work by reducing the production of stomach acid. PPIs help in treating conditions like gastroesophageal reflux disease (GERD) and peptic ulcers. Another essential class of agents is antacids, which neutralize excessive stomach acid, providing relief from heartburn and indigestion.

Gastrointestinal agents also include antispasmodics that alleviate abdominal cramps and spasms associated with conditions like IBS. These drugs work by relaxing the smooth muscles of the digestive tract. Additionally, there are drugs categorized as laxatives that aid in relieving constipation by promoting bowel movements.

Moreover, certain gastrointestinal agents act as antiemetics, effectively reducing nausea and vomiting. These drugs are particularly useful for patients undergoing chemotherapy or experiencing motion sickness.

Pharmaceutical companies develop and manufacture a wide range of gastrointestinal agents in various forms, including tablets, capsules, suspensions, and injections. These agents are typically formulated using active pharmaceutical ingredients (APIs) and other excipients to ensure their efficacy and safety.

In conclusion, gastrointestinal agents form a vital category of pharmaceutical APIs, providing relief from digestive disorders and improving overall gastrointestinal health. The availability of diverse agents catering to different conditions ensures that patients can receive targeted treatment for their specific gastrointestinal needs.

• Erregierre from Italy, product country of origin Italy

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.